Maverex are experts in market access and HEOR, including Market access strategy, HTA support, HE modelling, meta-analyses, value communications, RWE and environmental impact/sustainability.
We specialize in providing health economic, market access, epidemiological, environmental and outcomes research expertise to support pharmaceutical, medical device, and diagnostic companies demonstrate and communicate the value of their product, from early clinical development through to post-launch commercialisation. Our goal is to help maximise launch success.
We are a thriving senior team offering a range of core market access deliverables, including evidence generation (systematic reviews, meta-analyses, RWE, database analyses), value demonstration (health economics models), communication and payer negotiation materials (global value dossiers, negotiation strategies, publications, HTA submissions etc.), environmental impact/sustainability of disease pathways and products, and digital tools for internal use (like electronic global value dossiers) and field use (like payer toolkits and economic model apps).
Our collaborative, flexible approach, reputation for delivering high quality, insightful products, and exceptional customer service set us apart from other businesses in the field. We continually strive to achieve this through investing in our relationships and through our commitment to long-term collaborations with our customers. At Maverex we ensure that our customers always deal with the people actually doing the work, from the initial proposal right through to the final deliverable.
We understand the customer’s perspective as many of us were once the customer ourselves, and we care about the successful outcome of projects as much as our customers do.
Maverex is a team of highly experienced professionals with +20 years of experience and a wide skill base. Our scientists have a long track record in development of market access deliverables with experience working in pharma, consultancy and academia.

Media

---